PT Mobile Logo

Search form


Somatoform and Related Disorders: An Update

Somatoform and Related Disorders: An Update

Diagnostic categories regarding somatoform disorders in DSM-5 and DSM-IVTable 1 – Diagnostic categories regarding somatoform disorders in DSM-...
Andrew’s symptoms as they relate to DSM-5 criteria for somatic symptom disorderTable 2 – Andrew’s symptoms as they relate to DSM-5 criteria for somat...
Communication strategies for clinicians with somatic symptom patientsTable 3 – Communication strategies for clinicians who work with patien...
Andrew’s case based on the model of somatoform disordersFigure 1. Andrew’s case based on the model of somatoform disorders by ...
Short- and long-term positive & negative consequences of avoidance behaviorFigure 2. Short- and long-term positive and negative consequences of A...

PREMIERE DATE: September 20, 2015
EXPIRATION DATE: March 20, 2017

This activity offers CE credits for:
1. Physicians (CME)
2. Other


To understand how the changes in DSM-5 affect the diagnoses of somatic disorders and how to assess and treat a patient with somatic symptoms.


At the end of this CE activity, participants should be able to:

• Differentiate between DSM-5 somatic symptom and related disorders and DSM-IV somatoform disorders

• Incorporate DSM-5 criteria for somatoform disorder into their practice

• Understand the role of medically unexplained symptoms in somatic disorders


This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.


CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for 1.5 AMA PRA Category 1 Credit™.


It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.

The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Maria Kleinstäuber, PhD, has no disclosures to report.

Winfried Rief, PhD, has no disclosures to report.

Katharina Voigt, PhD (peer/content reviewer), has no disclosures to report.

Applicable Psychiatric Times staff and CME Outfitters staff have no disclosures to report.


Faculty of this CME/CE activity may include discussion of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767)


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.